Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (18th October 2019)

• Record Type: Journal Article
• Authors: Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Huang, Zhongwen; Boland, Brigid S; Shashi, Preeti; Weiss, Aaron; Hudesman, David; Varma, Sashidhar; Fischer, Monika; Sultan, Keith; Shen, Bo; Kane, Sunanda; Loftus, Edward V; Sands, Bruce E; Colombel, Jean-Frederic; Sandborn, William J; Lasch, Karen; Siegel, Corey A; Dulai, Parambir S;
• Is Part Of: Inflammatory bowel diseases. Volume 25:Issue 11(2019)
• Publication Date: 2019-10-18
• Subjects: vedolizumab -- trends utilization -- hospitalization -- surgery; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izz071
• Languages: English
• ISSNs: 1078-0998